Vanda Pharmaceuticals | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
Acadia Pharmaceuticals USD 126.37M 3.71M 2025-03
Agios Pharmaceuticals USD 41.53M 10.17M 2025-03
Alnylam Pharmaceuticals USD 239.95M 55.39M 2025-03
Arrowhead Research USD 27.89M 2.3M 2025-03
AstraZeneca USD 3.59B 1.96B 2025-03
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Eli Lilly USD 2.36B 62.3M 2025-03
Halozyme Therapeutics USD 42.36M 113K 2025-03
Insmed USD 147.54M 5.03M 2025-03
J&J USD 5.11B 1.34B 2025-03
Ligand Pharmaceuticals USD 18.8M 6.8M 2025-03
Merck USD 2.53B 319M 2025-03
Moderna USD 212M 139M 2025-03
Novartis USD 3.5B 368M 2024-12
Pfizer USD 3.01B 1.27B 2025-03
PTC Therapeutics USD 161.92M 77.24M 2025-03
Sanofi EUR 2.22B 980M 2025-03
Takeda JPY 295.87B 25.28B 2025-03
Teva Pharmaceutical Industries USD 919M 33M 2025-03
Ultragenyx Pharmaceutical USD 87.8M 5.3M 2025-03
Veracyte USD 59.16M 8.45M 2025-03



Vanda Pharmaceuticals Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.